Biomarker-positive EGFR/HER2- expressing HNSCC

Clinical trials for Biomarker-positive EGFR/HER2- expressing HNSCC explained in plain language.

Never miss a new study

Get alerted when new Biomarker-positive EGFR/HER2- expressing HNSCC trials appear

Sign up with your email to follow new studies for Biomarker-positive EGFR/HER2- expressing HNSCC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Supercharged immune cells take on Hard-to-Treat head and neck cancer

Disease control Recruiting now

This study tests a new treatment for adults with advanced head and neck cancer that has spread or come back. The treatment uses donor immune cells that are engineered to target two cancer markers, EGFR and HER2. Participants first receive chemotherapy to prepare their body, then …

Matched conditions: BIOMARKER-POSITIVE EGFR/HER2- EXPRESSING HNSCC

Phase 1/2 • Sponsor: Beijing Biotech • Aim: Disease control

Last updated Jun 27, 2026 13:00 UTC

Biomarker-positive EGFR/HER2- expressing HNSCC

Get alerted when new Biomarker-positive EGFR/HER2- expressing HNSCC trials appear

Supercharged immune cells take on Hard-to-Treat head and neck cancer